Amphotericin B Dosage for Systemic Fungal Infections
For systemic fungal infections, conventional amphotericin B deoxycholate should be dosed at 0.5-0.7 mg/kg/day IV for standard infections and up to 1.0 mg/kg/day for severe or life-threatening infections, while liposomal amphotericin B (the preferred lipid formulation) should be dosed at 3-5 mg/kg/day IV. 1, 2, 3
Conventional Amphotericin B Deoxycholate Dosing
Initial Dosing Strategy
- Start with a test dose of 1 mg in 20 mL of 5% dextrose administered over 20-30 minutes, monitoring vital signs every 30 minutes for 2-4 hours 3
- In patients with good cardio-renal function and well-tolerated test dose, initiate therapy at 0.25 mg/kg/day 3
- For severe and rapidly progressive fungal infections, begin at 0.3 mg/kg/day 3
- In patients with impaired cardio-renal function or severe test dose reaction, start with 5-10 mg daily and gradually increase by 5-10 mg increments 3
Maintenance Dosing
- Standard infections: 0.5-0.7 mg/kg/day IV 1, 2, 3
- Severe or life-threatening infections: 0.7-1.0 mg/kg/day IV 1, 4
- Maximum daily dose: Never exceed 1.5 mg/kg/day, as overdoses can result in potentially fatal cardiac or cardiopulmonary arrest 3
- Infusion duration: Administer over 2-6 hours at a concentration of 0.1 mg/mL (1 mg/10 mL) 3
Nephrotoxicity Prevention
- Administer 1 liter of 0.9% normal saline 30 minutes before infusion in patients who can tolerate fluids 1, 5
- Pre-medicate with acetaminophen or diphenhydramine to reduce infusion-related reactions (fever, chills, nausea) 4, 5
Lipid Formulations of Amphotericin B
Liposomal Amphotericin B (L-AmB) - Preferred Lipid Formulation
- Standard dosing: 3-5 mg/kg/day IV 1, 2
- CNS involvement: 5-10 mg/kg/day IV 5
- This formulation provides the greatest renal protection among all lipid formulations 2
- Significantly less nephrotoxic than conventional amphotericin B with equivalent or superior efficacy 6
Alternative Lipid Formulations
- Amphotericin B lipid complex (ABLC): 5 mg/kg/day IV 1, 2, 5
- Amphotericin B colloidal dispersion (ABCD): 3-6 mg/kg/day IV 2, 5
- Note: ABCD has higher rates of acute infusion reactions compared to liposomal amphotericin B 6
Evidence Supporting Lower Doses
- Low-dose liposomal amphotericin B (1 mg/kg/day) may be equally effective for some indications with comparable clinical improvement and survival rates 7
- However, avoid dosages as low as 1 mg/kg for initial treatment of fulminant fungal infections, as efficacy may be inferior 8
Infection-Specific Dosing
CNS Candidiasis (Meningitis)
- Initial treatment: Liposomal AmB 5 mg/kg/day IV, with or without flucytosine 25 mg/kg four times daily 1
- Continue until all signs, symptoms, CSF abnormalities, and radiological findings resolve 1
Candidal Chorioretinitis
- Fluconazole/voriconazole-resistant isolates: Liposomal AmB 3-5 mg/kg/day IV, with or without flucytosine 1
- With macular involvement or vitritis: Add intravitreal injection of amphotericin B deoxycholate 5-10 μg/0.1 mL sterile water 1, 5
- Duration: At least 4-6 weeks, continuing until lesion resolution on repeated ophthalmological examinations 1
Candiduria Requiring Treatment
- Patients undergoing urologic procedures: Amphotericin B deoxycholate 0.3-0.6 mg/kg/day for several days before and after the procedure 1
- Bladder irrigation (rarely indicated): 50 mg/L sterile water daily for 5 days 5
Neonatal Disseminated Candidiasis
- Amphotericin B deoxycholate 0.5-1 mg/kg/day for a total dose of 10-25 mg/kg 1
- Amphotericin B is well tolerated in neonates 1
Sporotrichosis
- Therapy may range up to 9 months with a total dose up to 2.5 g 3
Aspergillosis
- Treatment may extend up to 11 months with a total dose up to 3.6 g 3
Rhinocerebral Phycomycosis
- Cumulative dose of at least 3 g is recommended, with 3-4 g being a reasonable minimum for deep tissue invasion 3
- This fulminating disease requires aggressive therapy and restoration of diabetic control 3
Special Administration Routes
Intraventricular Administration
- For CNS devices that cannot be removed: Amphotericin B deoxycholate 0.01-0.5 mg in 2 mL of 5% dextrose in water 1, 5
Intravitreal Injection
Duration of Therapy
Candidemia
- Continue treatment for 14 days after the last positive blood culture and resolution of signs and symptoms 2, 4
Disseminated Candidiasis
- Treatment may last 3-6 months until resolution or calcification of radiologic lesions 2
Cryptococcal Meningitis
Monitoring Requirements
- Monitor renal function, electrolytes (especially potassium), and liver function tests regularly 2, 4, 5
- Watch for infusion-related reactions: fever, chills, nausea, vomiting, chest pain, dyspnea, hypoxia, severe abdominal/flank/leg pain, flushing, urticaria 5
- If infusion reactions occur, temporarily interrupt infusion and administer IV diphenhydramine 5
- For persistent candidemia despite appropriate therapy, investigate for deep tissue focus of infection 2, 4
Critical Preparation and Administration Warnings
- Never reconstitute with saline solutions—this causes precipitation 3
- Do not use diluents containing bacteriostatic agents (e.g., benzyl alcohol)—this causes precipitation 3
- Strict aseptic technique is mandatory, as no preservative is present 3
- If using an in-line membrane filter, the mean pore diameter must not be less than 1 micron 3
- Do not use if any evidence of precipitation or foreign matter is present 3
Common Pitfalls to Avoid
- Do not exceed 1.5 mg/kg/day of conventional amphotericin B—potentially fatal cardiac arrest can occur 3
- Do not skip pre-hydration with normal saline—this significantly increases nephrotoxicity risk 1, 5
- Do not use conventional amphotericin B when lipid formulations are available for patients with renal impairment 5
- Do not use low doses (1 mg/kg) for initial treatment of fulminant infections—efficacy may be compromised 8